Mandle R, Kaplan A P
J Biol Chem. 1977 Sep 10;252(17):6097-104.
Two molecular forms of prekallikrein can be isolated from pooled normal human plasma. Their approximate molecular weights by sodium dodecyl sulfate-gel electrophoresis are 88,000 and 85,000. The two bands observed are shown to represent prekallikrein by functional, immunochemical, and structural criteria. Both forms are cleaved by activated Hageman factor, they appear to share antigenic determinants, they are not interconvertible upon incubation with activated Hageman factor or kallikrein, and the ratio of kinin-generating, and plasminogen-activating activities of the preparations are independent of the relative proportion of each band. Activated Factor XII converts prekallikrein to kallikrein by limited proteolysis and two disulfide-linked chains designated kallikrein heavy chain (Mr = 52,000) and kallikrein light chains (Mr = 36,000 or 33,000) are formed. The active site is associated with the light chains as assessed by incorporation of [3H]diisopropyl fluorophosphate. No dissociable fragments were observed in the absence of reducing agents. However, kallikrein could digest prekallikrein to diminish its molecular weight by 10,000. In addition, two factors capable of activating plasminogen to plasmin have been isolated; one is identified as kallikrein. The second principle fractionates with Factor XI and is demonstrable in normal and prekallikrein-deficient plasma.
可从混合的正常人血浆中分离出两种分子形式的前激肽释放酶。通过十二烷基硫酸钠-凝胶电泳测定,它们的近似分子量分别为88,000和85,000。通过功能、免疫化学和结构标准表明,观察到的两条带代表前激肽释放酶。两种形式均被活化的Hageman因子裂解,它们似乎具有共同的抗原决定簇,在与活化的Hageman因子或激肽释放酶孵育时它们不能相互转化,并且制剂的激肽生成活性和纤溶酶原激活活性的比例与每条带的相对比例无关。活化的因子XII通过有限的蛋白水解作用将前激肽释放酶转化为激肽释放酶,并形成两条二硫键连接的链,分别称为激肽释放酶重链(Mr = 52,000)和激肽释放酶轻链(Mr = 36,000或33,000)。通过掺入[3H]二异丙基氟磷酸评估,活性位点与轻链相关。在没有还原剂的情况下未观察到可解离的片段。然而,激肽释放酶可以消化前激肽释放酶,使其分子量降低10,000。此外,已分离出两种能够将纤溶酶原激活为纤溶酶的因子;一种被鉴定为激肽释放酶。第二种主要成分与因子XI一起分级分离,并且在正常血浆和前激肽释放酶缺乏的血浆中均可检测到。